Show simple item record

dc.contributor.authorMi, Fenglingen_US
dc.contributor.authorJiang, Guangluen_US
dc.contributor.authorDu, Jianen_US
dc.contributor.authorLi, Liangen_US
dc.contributor.authorYue, Wentaoen_US
dc.contributor.authorHarries, Anthony D.en_US
dc.contributor.authorHinderaker, Sven Gudmunden_US
dc.contributor.authorLin, Yanen_US
dc.description.abstractBackground: China has a high burden of drug-resistant tuberculosis (TB) and diabetes mellitus (DM). Objective: The objectives of this study were to determine the following in patients with culture-confirmed TB: 1) demographic characteristics and disease patterns in relation to the presence or absence of type 2 diabetes and 2) presence or absence of drug resistance to isoniazid (INH), rifampicin (RMP) or both in relation to duration of diabetes and control of diabetes. Design: This is a cross-sectional and retrospective study involving record reviews. Results: There were 621 patients with culture-positive TB, of whom 187 (30%) had previously known or new type 2 diabetes. In those with diabetes, there was a significantly higher proportion of males, persons aged ≥35 years and patients registered with new TB (p<0.05). Prevalence of multidrug-resistant TB (MDR-TB) was 6.2% in new patients (N=422) and 62.3% in previously treated patients (N=199), with no significant differences between those with and without diabetes. In patients with diabetes, there was no association of drug resistance with diabetes duration or disease control [assessed by fasting blood glucose (FBG) at 1 week]. Conclusion: A high proportion of patients with TB in a tertiary health facility, Beijing, China, had diabetes, but there was no association between type 2 diabetes and drug-resistant TB. Further prospective studies are needed to confirm these findings.en_US
dc.publisherCo-Action Publishingeng
dc.rightsAttribution CC BYeng
dc.subjectDiabetes mellituseng
dc.subjectdiabetes durationeng
dc.subjectdiabetes controleng
dc.subjectmultidrug-resistant tuberculosiseng
dc.titleIs resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, Chinaen_US
dc.typePeer reviewed
dc.typeJournal article
dc.rights.holderCopyright 2014 Fengling Mi et al.
dc.source.journalGlobal health action
dc.subject.nsiVDP::Medical sciences: 700::Clinical medical sciences: 750::Endocrinology: 774eng
dc.subject.nsiVDP::Medical sciences: 700::Basic medical, dental and veterinary sciences: 710::Clinical pharmacology: 739eng
dc.subject.nsiVDP::Medical sciences: 700::Clinical medical sciences: 750::Lung diseases: 777eng
dc.subject.nsiVDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Endokrinologi: 774nob
dc.subject.nsiVDP::Medisinske fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Klinisk farmakologi: 739nob
dc.subject.nsiVDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Lungesykdommer: 777nob

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY